SNGX (STOCKS)
Soligenix, Inc. Common Stock
$0.380900
-0.009100 (-2.33%)
Prev close: $0.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher J. Schaber
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8.52M
- Employees
- 16
- P/E (TTM)
- -0.31
- P/B (TTM)
- 1.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $293.32K |
| Operating Expenses | $11.04M |
| Research and Development | $6.62M |
| Other Operating Expenses | $4.42M |
| Operating Income/Loss | -$11.04M |
| Income/Loss From Continuing Operations After Tax | -$10.24M |
| Income/Loss From Continuing Operations Before Tax | -$10.75M |
| Net Income/Loss | -$10.24M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.24M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.24M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.79 |
| Diluted Earnings Per Share | -$0.79 |
| Basic Average Shares | 19,108,025 |
| Diluted Average Shares | 19,108,025 |
| Assets | $10.50M |
| Current Assets | $10.17M |
| Prepaid Expenses | $355.45K |
| Other Current Assets | $9.82M |
| Noncurrent Assets | $327.68K |
| Fixed Assets | $6.58K |
| Other Non-current Assets | $321.11K |
| Liabilities | $3.85M |
| Current Liabilities | $3.67M |
| Accounts Payable | $1.41M |
| Wages | $84.05K |
| Other Current Liabilities | $2.18M |
| Noncurrent Liabilities | $182.07K |
| Equity | $6.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.65M |
| Liabilities And Equity | $10.50M |
| Net Cash Flow From Operating Activities | -$9.74M |
| Net Cash Flow From Operating Activities, Continuing | -$9.74M |
| Net Cash Flow From Investing Activities | -$1.88M |
| Net Cash Flow From Investing Activities, Continuing | -$1.88M |
| Net Cash Flow From Financing Activities | $14.46M |
| Net Cash Flow From Financing Activities, Continuing | $14.46M |
| Net Cash Flow | $2.84M |
| Net Cash Flow, Continuing | $2.84M |
| Comprehensive Income/Loss | -$10.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.24M |
| Other Comprehensive Income/Loss | -$2.53M |